medicines

Sales & Marketing

ADHD medication scarcity adds to questions on US supply chai...

Ben Hargreaves looks into why ADHD medicines are still suffering shortages nearly a year after first being announced.

Market Access

Breaking through the forecasting fog - 3 trends that will im...

As the legendary investor Warren Buffett once said, forecasts about the future usually tell you more about the forecaster than they do about the future.

Market Access

Nine for 2023, part one: a reflection on inflection

The Roman god Janus, as we are frequently reminded in January, was two faced and able to look forward to the coming year and backward to reflect on the past one.

Pharma Market Access

Pharma manufacturing can digitalise its way round the next c...

The turbulence of the last three years can make it seem as though pharma manufacturers have been operating in an atmosphere of non-stop crisis.

Views & Analysis

Spotlight on women in pharma: Şeyda Atadan Memiş, Takeda

As part of our Women in Pharma series, where we talk to leading figures in the life sciences, we hear from Şeyda Atadan Memiş, recently appointed general manager for Takeda UK and

News

group of chemical scientists working at the laboratory.

BMA responds to ABPI report, warns UK losing research leader...

In response to the recent Association of British Pharmaceutical Industry (ABPI) report, which showed a sharp decline (41%) in clinical trials initiated by the UK in the period 2017 to 2021,